Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCooper Financial Group
Latest Disclosed Ownership5,742 shares
Latest Disclosed Value $ 800,253
Cooper Financial Group reports 21.47% increase in ownership of GILD / Gilead Sciences, Inc.

On April 7, 2026 - Cooper Financial Group filed a 13F-HR form disclosing ownership of 5,742 shares of Gilead Sciences, Inc. (CH:GILD) valued at $800,253 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 4,727 shares of Gilead Sciences, Inc.. This represents a change in shares of 21.47% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F GILEAD SCIENCES COM 375558103 5,742 1,015 21.47 800 37.93 0.0809
2026-01-08 2025-12-31 13F GILEAD SCIENCES COM 375558103 4,727 607 14.73 580 26.91 0.0617
2025-10-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 4,120 1,517 58.28 457 58.68 0.0506
2025-07-18 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,603 261 11.14 289 9.92 0.0339
2025-05-12 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,342 2,342 262 0.0346
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 0 -7,209 -100.00 0 -100.00
2024-07-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 7,209 4,463 162.53 495 145.77 0.0727
2024-04-11 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,746 -291 -9.58 201 -18.29 0.0331
2024-01-16 2023-12-31 13F GILEAD SCIENCES COM 375558103 3,037 3,037 246 0.0447
2023-07-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 0 -2,915 -100.00 0 -100.00
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,915 543 22.89 242 18.72 0.0652
2023-01-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,372 2,372 204 0.0622
2020-10-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -4,584 -100.00 0 -100.00
2020-07-15 2020-06-30 13F GILEAD SCIENCES COM 375558103 4,584 80 1.78 353 4.75 0.1143
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 4,504 308 7.34 337 23.44 0.1405
2020-01-07 2019-12-31 13F GILEAD SCIENCES COM 375558103 4,196 195 4.87 273 7.48 0.1093
2019-10-08 2019-09-30 13F GILEAD SCIENCES COM 375558103 4,001 397 11.02 254 4.53 0.1145
2019-07-08 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,604 149 4.31 243 8.00 0.1178
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 3,455 211 6.50 225 10.84 0.1240
2019-01-17 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,244 3,244 203 0.1376
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.